Largest Insider Stock Purchases Belonged in Biotech and Energy the Week of 9/18/23
Two verticals constituted the lion share of insider purchases last week. In biotech, Neumora Therapeutics (NMRS) saw Amgen (AMGN) and the CEO buying shares. Rayzebio (RYZB) and Ambrx Bio (AMAM) also saw large insider accumulation. In the energy field, Chargepoint Holding (CHPT), Highpeak Energy (HPK) (where both the CEO and the President bought), Enphase Energy (ENPH), CNX Resources (CNX), and Riley Exploration (REPX) also saw insiders acquire substantial amounts of shares. Outside the biotech and energy verticals, of note are insider purchases at Maplebear (Instacart) (CART), Asana (ASAN) (where the CEO has been buying shares for months), and Westrock Coffee (WEST). CHPT buyer Wil VanLoh founded Quantum Energy Partners in 1998 and serves as CEO of the firm and as Chairman...
Revisiting Insider Purchases Made the Second Week of May 2021: Scary!
Insiders purchased a lot shares of biotech and small medical device companies the Second Week of May 2021 (often shortly after IPO), only to lose their shirt! If you followed the smart crowd, and invested at around the same time, you are probably sitting on severe losses. Most stocks have seen an at least 50% haircut, and that's after accounting for some of the recovery of late. Neurospace (NPCE), Design Therapeutics (DSGN), Werewolf Therapeutics (WOLF), Reneo Pharmaceuticals (RPHM), Cyclerion Therapeutics (CYCN), and Nuvation Bio (NUVB), to name a few, have all collapsed or near-collapsed. A couple of stocks are indeed trying to recover. Unsurprisingly, all of the above are unprofitable ventures. The lesson is clear. Best to stay away from unprofitable biotech and...
Insiders Buy Shares at Varonis Systems
Key insiders including the CEO, CFO, and SVP of Sales, bought shares of Varonis Systems (VRNS). All three are key decision-makers. the purchases are also large enough that they warrant scrutiny. The Company is expected to be profitable over the next couple of years, as is made clear below: Meanwhile, the 17 analysts offering 12-month price forecasts for Varonis Systems have a median target of 25.00, with a high estimate of 63.00 and a low estimate of 20.00. The median estimate represents a +50.69% increase from the last price of 16.59. After their recent collapse (see stock chart below), the shares seem rather cheap. Varonis Systems, Inc. (Varonis)...